637,314 Shares in Definitive Healthcare Corp. (NASDAQ:DH) Acquired by 272 Capital LP

272 Capital LP bought a new stake in Definitive Healthcare Corp. (NASDAQ:DH) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 637,314 shares of the company’s stock, valued at approximately $3,480,000. Definitive Healthcare makes up about 1.7% of 272 Capital LP’s investment portfolio, making the stock its 22nd biggest position. 272 Capital LP owned about 0.54% of Definitive Healthcare as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. Marshall Wace LLP bought a new stake in Definitive Healthcare during the second quarter worth about $1,535,000. Canada Pension Plan Investment Board purchased a new position in shares of Definitive Healthcare during the 2nd quarter valued at about $109,000. Granite Investment Partners LLC lifted its position in Definitive Healthcare by 22.5% in the 2nd quarter. Granite Investment Partners LLC now owns 884,872 shares of the company’s stock worth $4,831,000 after buying an additional 162,432 shares during the last quarter. Hsbc Holdings PLC purchased a new stake in Definitive Healthcare in the second quarter worth approximately $127,000. Finally, Renaissance Technologies LLC boosted its stake in Definitive Healthcare by 50.5% in the second quarter. Renaissance Technologies LLC now owns 28,900 shares of the company’s stock worth $158,000 after buying an additional 9,700 shares in the last quarter. 98.67% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

DH has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a report on Friday, August 9th. BTIG Research initiated coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price target for the company. Stifel Nicolaus reduced their price objective on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a research note on Wednesday, July 31st. JPMorgan Chase & Co. lowered Definitive Healthcare from a “neutral” rating to an “underweight” rating and lowered their target price for the company from $7.00 to $5.00 in a research note on Wednesday, July 31st. Finally, Morgan Stanley reduced their price target on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating on the stock in a research report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Definitive Healthcare presently has an average rating of “Hold” and a consensus target price of $5.81.

Definitive Healthcare Trading Down 4.0 %

NASDAQ DH opened at $4.32 on Tuesday. The stock has a market cap of $509.48 million, a P/E ratio of -2.47, a price-to-earnings-growth ratio of 6.38 and a beta of 1.33. Definitive Healthcare Corp. has a fifty-two week low of $3.19 and a fifty-two week high of $10.62. The stock has a 50 day simple moving average of $4.59 and a two-hundred day simple moving average of $5.81. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.40 and a current ratio of 2.40.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The business had revenue of $63.70 million for the quarter, compared to analysts’ expectations of $63.19 million. During the same quarter in the previous year, the business posted $0.08 earnings per share. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. On average, analysts forecast that Definitive Healthcare Corp. will post 0.07 earnings per share for the current year.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.